<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Genet.</journal-id>
<journal-title>Frontiers in Genetics</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Genet.</abbrev-journal-title>
<issn pub-type="epub">1664-8021</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1368915</article-id>
<article-id pub-id-type="doi">10.3389/fgene.2024.1368915</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Genetics</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Absence of causative genetic association between <italic>Helicobacter pylori</italic> infection and glaucoma: a bidirectional two-sample mendelian randomization study</article-title>
<alt-title alt-title-type="left-running-head">Zhang et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fgene.2024.1368915">10.3389/fgene.2024.1368915</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Zhang</surname>
<given-names>Yan</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>&#x2020;</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Huang</surname>
<given-names>Yihong</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>&#x2020;</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Wu</surname>
<given-names>Yuyu</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>&#x2020;</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Zhang</surname>
<given-names>Jinying</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>&#x2020;</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chen</surname>
<given-names>Wanzhu</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Xu</surname>
<given-names>Danfeng</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Guo</surname>
<given-names>Maosheng</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2627608/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Ophthalmology</institution>, <institution>Second Affiliated Hospital of Fujian Medical University</institution>, <addr-line>Quanzhou</addr-line>, <addr-line>Fujian</addr-line>, <country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Department of Neurology</institution>, <institution>Second Affiliated Hospital of Fujian Medical University</institution>, <addr-line>Quanzhou</addr-line>, <addr-line>Fujian</addr-line>, <country>China</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Department of Ultrasound</institution>, <institution>Second Affiliated Hospital of Fujian Medical University</institution>, <addr-line>Quanzhou</addr-line>, <addr-line>Fujian</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/568466/overview">Maria Oana Sasaran</ext-link>, Sciences and Technology of T&#xe2;rgu Mure&#x219;, Romania</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1460618/overview">Valeria Lo Faro</ext-link>, Uppsala University, Sweden</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1814989/overview">Youjie Zeng</ext-link>, Central South University, China</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Maosheng Guo, <email>guomaoshenggms@126.com</email>
</corresp>
<fn fn-type="equal" id="fn001">
<label>
<sup>&#x2020;</sup>
</label>
<p>These authors have contributed equally to this work</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>24</day>
<month>05</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>15</volume>
<elocation-id>1368915</elocation-id>
<history>
<date date-type="received">
<day>11</day>
<month>01</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>02</day>
<month>05</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2024 Zhang, Huang, Wu, Zhang, Chen, Xu and Guo.</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Zhang, Huang, Wu, Zhang, Chen, Xu and Guo</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>
<bold>Background:</bold> While clinical research has indicated a potential link between <italic>Helicobacter pylori</italic> infection and the onset of glaucoma, the causality of this association remains uncertain due to the susceptibility of observational studies to confounding factors and reverse causation.</p>
<p>
<bold>Methods:</bold> A comprehensive two-sample bidirectional Mendelian randomization (MR) analysis was conducted to assess the causal connection between <italic>H. pylori</italic> infection and glaucoma. Glaucoma was categorized into primary open-angle glaucoma (POAG), normal tension glaucoma (NTG), and pseudo-exfoliation glaucoma (PEG). Various methods, including inverse variance weighted, MR-Egger regression, weighted median, and mode-based estimator, were employed for effect estimation and pleiotropy testing. To enhance result robustness, a sensitivity analysis was performed by excluding proxy single nucleotide polymorphisms.</p>
<p>
<bold>Results:</bold> Genetic predisposition for <italic>H. pylori</italic> infection has no causal effect on glaucoma: (OR 1.00; 95% CI 0.95&#x2013;1.06, <italic>p</italic> &#x003D; 0.980), (OR 0.97; 95% CI 0.86&#x2013;1.09, <italic>p</italic> &#x003D; 0.550), and (OR 0.99; 95% CI 0.90&#x2013;1.08, <italic>p</italic> &#x003D; 0.766) with POAG, NTG, and PEG, respectively. An inverse MR showed no causal effect of POAG, NTG, and PEG on <italic>H. pylori</italic> infection (OR 1.01; 95% CI 0.97&#x2013;1.05, <italic>p</italic> &#x003D; 0.693), (OR 1.00; 95% CI 0.98&#x2013;1.03, <italic>p</italic> &#x003D; 0.804), and (OR 0.99; 95% CI 0.96&#x2013;1.01, <italic>p</italic> &#x003D; 0.363), respectively. Heterogeneity (<italic>p</italic> &#x003e; 0.05) and pleiotropy (<italic>p</italic> &#x003e; 0.05) analysis confirmed the robustness of MR results.</p>
<p>
<bold>Conclusion:</bold> These results indicated that there was no genetic evidence for a causal link between <italic>H. pylori</italic> and glaucoma, suggesting that the eradication or prevention of <italic>H. pylori</italic> infection might not benefit glaucoma and <italic>vice versa</italic>.</p>
</abstract>
<kwd-group>
<kwd>
<italic>Helicobacter pylori</italic>
</kwd>
<kwd>mendelian randomization</kwd>
<kwd>normal tension glaucoma</kwd>
<kwd>primary open-angle glaucoma</kwd>
<kwd>pseudo-exfoliation glaucoma</kwd>
</kwd-group>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Applied Genetic Epidemiology</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1">
<title>1 Introduction</title>
<p>Glaucoma, the second leading cause of blindness globally following cataracts, results in the death of retinal ganglion cells and their axons (<xref ref-type="bibr" rid="B10">Kingman, 2004</xref>). It is anticipated that by the year 2040, glaucoma will impact approximately 111.8 million individuals globally, establishing itself as the predominant cause of irreversible vision impairment (<xref ref-type="bibr" rid="B18">Tham et al., 2014</xref>). The pathophysiology of glaucoma involves various factors, including infection with <italic>H. pylori</italic>&#x2014;a widespread pathogen linked to conditions such as Alzheimer&#x2019;s disease, gastritis, gastric ulcers, and gastric carcinomas (<xref ref-type="bibr" rid="B19">Tsolaki et al., 2012</xref>). The investigation into the potential association between <italic>H. pylori</italic> infection and glaucoma dates back to 2001 when Kountouras et al. were among the first to explore this connection (<xref ref-type="bibr" rid="B11">Kountouras et al., 2001</xref>). In the subsequent two&#xa0;decades, researchers worldwide have delved into this issue, leading to ongoing controversy surrounding the proposed relationship.</p>
<p>A recent comprehensive review and meta-analysis demonstrated a notable connection between <italic>H. pylori</italic> infection and the overall occurrence of glaucoma, revealing a significant association (OR &#x003D; 2.08, CI 95% 1.48&#x2013;2.93) despite a moderate degree of heterogeneity (I2 &#x003D; 61.54%) (<xref ref-type="bibr" rid="B6">Doulberis et al., 2020</xref>). It is important to note that the studies included in this meta-analysis were observational in nature, making it difficult to establish a definitive causal relationship. The question remains whether there is a cause-and-effect link between these two conditions or if they share common predisposing or precipitating factors. To address this uncertainty, a bidirectional two-sample Mendelian randomization (MR) analysis was conducted to clarify the causal relationship between genetically predicted <italic>H. pylori</italic> infection and the occurrence of glaucoma.</p>
<p>Mendelian randomization (MR) analysis has emerged as a powerful tool in epidemiological research for assessing causal relationships between exposures and outcomes. Unlike observational studies, MR analysis utilizes genetic variants, such as single nucleotide polymorphisms (SNPs), as instrumental variables to mimic randomized controlled trials, thereby providing more robust evidence of causality. These genetic variants are randomly allocated at conception and are typically unaffected by environmental confounders, making them ideal instruments for investigating causal associations (<xref ref-type="bibr" rid="B17">Swanson et al., 2017</xref>).</p>
<p>Previous studies have explored the causal relationship between dried fruit intake and cardiovascular disease risk, offering insights into dietary interventions for cardiovascular health. Another investigated the bidirectional relationship between gastroesophageal reflux disease and anxiety disorders and depression, unraveling potential pathways linking gastrointestinal health to mental wellbeing. Additionally, research into the roles of the gut microbiome in epilepsy risk has utilized Mendelian randomization to uncover potential mechanisms underlying neurological disorders. These studies exemplify the versatility and applicability of Mendelian randomization in elucidating causal pathways in complex diseases, paving the way for targeted interventions and improved public health strategies (<xref ref-type="bibr" rid="B21">Zeng et al., 2023a</xref>; <xref ref-type="bibr" rid="B22">Zeng et al., 2023b</xref>; <xref ref-type="bibr" rid="B23">Zeng et al., 2023c</xref>).</p>
<p>In our study, we employed a two-sample MR analysis to predict the likelihood of <italic>H. pylori</italic> infection and evaluate its potential association with glaucoma using independent, population-scale GWAS data for glaucoma. Furthermore, we investigated the possibility of reverse causation by considering the incidence of glaucoma as the exposure variable. Our aim was to elucidate the causal relationship between <italic>H. pylori</italic> infection and glaucoma, offering valuable insights for clinical practice.</p>
</sec>
<sec id="s2" sec-type="materials|methods">
<title>2 Materials and methods</title>
<sec id="s2-1">
<title>2.1 Assumptions and study design of MR</title>
<p>The evaluation of causal relationships between glaucoma and <italic>H. pylori</italic> infection was conducted using bidirectional two-sample MR analysis. Summary-level data for <italic>H. pylori</italic> infection and glaucoma were acquired from genome-wide relationship studies (GWAS). In this study, genetic variants were employed as instrument variables (IVs) for the MR analysis. Furthermore, the MR analysis adhered to three core assumptions (<xref ref-type="fig" rid="F1">Figure 1</xref>) to ensure reliable results (<xref ref-type="bibr" rid="B5">Davey Smith and Hemani, 2014</xref>): (1) the relevance assumption, indicating strong association of genetic variants with the exposure; (2) the independence assumption, asserting that genetic variants are not linked to any confounders that could mediate pathways from exposure to outcome; and (3) the exclusion-restriction assumption, positing that genetic variants solely influence the outcome through the exposure. Our findings were reported in accordance with the MRSTROBE guidance (<xref ref-type="bibr" rid="B15">Skrivankova et al., 2021</xref>). The de-identified public data used in this study for summary-level information is available for download, and ethical approval was obtained from the respective institutions for each GWAS involved in the study.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Schematic representation of the bidirectional MR study on the causal relationship between <italic>H. pylori</italic> infection and glaucoma.</p>
</caption>
<graphic xlink:href="fgene-15-1368915-g001.tif"/>
</fig>
</sec>
<sec id="s2-2">
<title>2.2 Data sources description</title>
<sec id="s2-2-1">
<title>2.2.1 Data sources</title>
<p>The <italic>H. pylori</italic> infection GWAS summary data were sourced from the publicly available dataset compiled in the European Bioinformatics Institute (EBI) database, accessible at <ext-link ext-link-type="uri" xlink:href="https://gwas.mrcieu.ac.uk/datasets/ieu-b-4905/">https://gwas.mrcieu.ac.uk/datasets/ieu-b-4905/</ext-link>. Additionally, the GWAS summary statistics for glaucoma, with further divisions into primary open-angle glaucoma (POAG), normal tension glaucoma (NTG), and pseudo-exfoliation glaucoma (PEG) were retrieved from the FinnGen research project database. The specific URLs for the glaucoma data are as follows: <ext-link ext-link-type="uri" xlink:href="https://gwas.mrcieu.ac.uk/datasets/finn-b-H7_GLAUCPRIMOPEN/">https://gwas.mrcieu.ac.uk/datasets/finn-b-H7_GLAUCPRIMOPEN/</ext-link>, <ext-link ext-link-type="uri" xlink:href="https://gwas.mrcieu.ac.uk/datasets/finn-b-H7_GLAUCOMA_NTG/">https://gwas.mrcieu.ac.uk/datasets/finn-b-H7_GLAUCOMA_NTG/</ext-link>, and <ext-link ext-link-type="uri" xlink:href="https://gwas.mrcieu.ac.uk/datasets/finn-b-H7_GLAUCOMA_XFG/">https://gwas.mrcieu.ac.uk/datasets/finn-b-H7_GLAUCOMA_XFG/</ext-link>. Detailed information about the GWAS data used in this study can be found in <xref ref-type="table" rid="T1">Table 1</xref>.</p>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>Details of the studies included in the Mendelian randomization analyses.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Phenotype</th>
<th align="left">Consortium</th>
<th align="left">Ethnicity</th>
<th align="left">Sample size</th>
<th align="left">Year</th>
<th align="left">Number of SNPs</th>
<th align="center">Web source</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">H.pylori</td>
<td align="left">MRC-IEU</td>
<td align="left">European</td>
<td align="left">4,683participants</td>
<td align="left">2021</td>
<td align="left">7,247,045</td>
<td align="right">
<ext-link ext-link-type="uri" xlink:href="https://gwas.mrcieu.ac.uk/datasets/ieu-b-4905/">https://gwas.mrcieu.ac.uk/datasets/ieu-b-4905/</ext-link>
</td>
</tr>
<tr>
<td align="left">POAG</td>
<td align="left">FinnGenstuy</td>
<td align="left">European</td>
<td align="left">4,433cases and 210,201controls</td>
<td align="left">2021</td>
<td align="left">16,380,455</td>
<td align="right">
<ext-link ext-link-type="uri" xlink:href="https://gwas.mrcieu.ac.uk/datasets/finn-b-H7_GLAUCPRIMOPEN/">https://gwas.mrcieu.ac.uk/datasets/finn-b-H7_GLAUCPRIMOPEN/</ext-link>
</td>
</tr>
<tr>
<td align="left">NTG</td>
<td align="left">FinnGenstuy</td>
<td align="left">European</td>
<td align="left">892cases and 210,201controls</td>
<td align="left">2021</td>
<td align="left">16,380,447</td>
<td align="right">
<ext-link ext-link-type="uri" xlink:href="https://gwas.mrcieu.ac.uk/datasets/finn-b-H7_GLAUCOMA_NTG/">https://gwas.mrcieu.ac.uk/datasets/finn-b-H7_GLAUCOMA_NTG/</ext-link>
</td>
</tr>
<tr>
<td align="left">PEG</td>
<td align="left">FinnGenstuy</td>
<td align="left">European</td>
<td align="left">1515cases and 210,201controls</td>
<td align="left">2021</td>
<td align="left">16,380,448</td>
<td align="right">
<ext-link ext-link-type="uri" xlink:href="https://gwas.mrcieu.ac.uk/datasets/finn-b-H7_GLAUCOMA_XFG/">https://gwas.mrcieu.ac.uk/datasets/finn-b-H7_GLAUCOMA_XFG/</ext-link>
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>Note: SNP, single-nucleotide polymorphisms; H.pylor, <italic>Helicobacter pylori</italic>; EBI, european bioinformatics institute; POAG, primary open-angle glaucoma; NTG, normal tension glaucoma; PEG, pseudo-exfoliation glaucoma.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s2-2-2">
<title>2.2.2 Selection of IVs</title>
<p>To ensure the robustness of the data and the accuracy of the results, a quality check was conducted on the single nucleotide polymorphisms (SNPs) to obtain valid IVs. This involved two criteria: (1) SNPs had to reach the genome-wide significance threshold (<italic>p</italic> &#x003c; 5 &#xd7; 10<sup>&#x2212;8</sup>). Since the number of eligible IVs at this threshold was limited, a more inclusive threshold (<italic>p</italic> &#x003c; 5 &#xd7; 10<sup>&#x2212;5</sup>) was chosen to ensure a more comprehensive result. (2) To satisfy the assumptions of MR, a linkage disequilibrium (LD) analysis was performed using the European-based 1,000 Genome Projects. SNPs failing to meet the criteria (R2 &#x003c; 0.001, clumping distance &#x003D; 10,000&#xa0;kb) were excluded. (3) Palindromic SNPs were also eliminated to mitigate the potential influence of alleles on establishing causality between <italic>H. pylori</italic> infection and glaucoma.</p>
</sec>
</sec>
<sec id="s2-3">
<title>2.3 Statistical analysis</title>
<p>Statistical analyses were conducted using R software (Version 4.1.1), employing the &#x201c;TwoSampleMR&#x201d; R package for conducting MR analysis to assess the causal link between <italic>H. pylori</italic> infection and glaucoma. A significance level of <italic>p</italic> &#x003c; 0.05 was utilized to determine the statistical significance, indicating potential evidence for a causal effect.</p>
<sec id="s2-3-1">
<title>2.3.1 MR analysis</title>
<p>The Wald ratio (WR) approach was employed to investigate the impact of individual IVs on the causal estimates. In cases without horizontal pleiotropy, the inverse variance weighted (IVW) test served as the primary method for computing unbiased estimates of the causal effects. The choice between a fixed or random effects model for the IVW test was determined by the presence or absence of heterogeneity. The effect size was expressed through OR and their corresponding 95% confidence intervals (CI). Additional methods for MR analysis included the (Weighted Median) WM method (<xref ref-type="bibr" rid="B3">Bowden et al., 2016</xref>) and the MR-Egger test (<xref ref-type="bibr" rid="B2">Bowden et al., 2015</xref>). WM results were considered significant causal effect values when the number of SNPs exhibiting heterogeneity surpassed 50%, while the MR-Egger results remained valid when SNPs with pleiotropy exceeded 50%.</p>
</sec>
<sec id="s2-3-2">
<title>2.3.2 Sensitivity analysis</title>
<p>The heterogeneity was examined using the Cochrane&#x2019;s Q test, and variables with a <italic>p</italic> &#x003c; 0.05 were regarded as heterogeneous. The MR-Egger regression&#x2019;s intercept was employed to evaluate potential pleiotropy in instrumental variables, with horizontal pleiotropy considered absent if <italic>p</italic> &#x003e; 0.05. To enhance data robustness, the leave-one-out method was also employed for validation.</p>
</sec>
</sec>
</sec>
<sec id="s3" sec-type="results">
<title>3 Results</title>
<p>To conduct the MR analysis, a broader significance threshold (<italic>p</italic> &#x003c; 5 &#xd7; 10<sup>&#x2212;5</sup>) was chosen due to zero number of eligible IVs (<italic>p</italic> &#x003c; 5 &#xd7; 10<sup>&#x2212;8</sup>). Significant and independent SNPs were included, while those with an F-statistics &#x003c;10 were excluded (F statistics &#x003D; R2 (<italic>n</italic> &#x2212; k &#x2212; 1)/k (1 &#x2212; R2), where R2 refers to variance of exposure explained by selected IVs, n refers to the sample size, and k refers to the number of IVs).Ultimately, a total of 66, 110, 68, and 60 SNPs related to <italic>H. pylori</italic> infection, POAG, NTG, and PEG were selected for the two-sample MR analysis.</p>
<p>An IVW model incorporating random effects produced a combined MR estimate indicating that there is no evidence to substantiate a causal link with <italic>H. pylori</italic>: (OR 1.00; 95% CI 0.95&#x2013;1.06, <italic>p</italic> &#x003D; 0.980), (OR 0.97; 95% CI 0.86&#x2013;1.09, <italic>p</italic> &#x003D; 0.550), and (OR 0.99; 95% CI 0.90&#x2013;1.08, <italic>p</italic> &#x003D; 0.766) with POAG, NTG, and PEG, respectively (<xref ref-type="fig" rid="F2">Figure 2</xref>; <xref ref-type="table" rid="T2">Table 2</xref>). An inverse MR showed no causal effect of POAG, NTG, and PEG on <italic>H. pylori</italic> infection (OR 1.01; 95% CI 0.97&#x2013;1.05, <italic>p</italic> &#x003D; 0.693), (OR 1.00; 95% CI 0.98&#x2013;1.03, <italic>p</italic> &#x003D; 0.804), and (OR 0.99; 95% CI 0.96&#x2013;1.01, <italic>p</italic> &#x003D; 0.363), respectively (<xref ref-type="fig" rid="F3">Figures 3</xref>&#x2013;<xref ref-type="fig" rid="F5">5</xref>). The outcomes from assessing candidate SNPs using weighted median and weighted mode estimates closely resembled those obtained from the random-effects IVW model. No indications of heterogeneity were observed in the IVW and MR-Egger analyses (<italic>p</italic> &#x003e; 0.05). Additionally, no evidence of directional horizontal pleiotropy was identified in the analysis, as evidenced by the MR-Egger intercept test (<italic>p</italic> &#x003e; 0.05). Further scrutiny through leave-one-out analysis, MRPRESSO, and funnel plot analysis failed to identify any significant outliers.</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Forest plot of Mendelian randomization results of <italic>H. pylori</italic> effect on POAG, NTG, and PEG. ieu-b-4905 is the <italic>H. pylori</italic> infection GWAS summary data, finn-b-H7_GLAUCPRIMOPEN is the primary open-angle glaucoma GWAS summary data, finn-b-H7_GLAUCOMA_NTG is the normal tension glaucoma GWAS summary data, finn-b-H7_GLAUCOMA_XFG is the pseudo-exfoliation glaucoma GWAS summary data.</p>
</caption>
<graphic xlink:href="fgene-15-1368915-g002.tif"/>
</fig>
<table-wrap id="T2" position="float">
<label>TABLE 2</label>
<caption>
<p>Forest plot of Mendelian randomization results of HP effect on POAG, NTG, and PEG.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left" rowspan="2">Exposure</th>
<th align="left" rowspan="2">Outcome</th>
<th align="left" rowspan="2">N. SNPs</th>
<th align="left" colspan="2">IVW</th>
<th align="left" rowspan="2">Pval</th>
<th align="left" colspan="2">Heterogeneity</th>
<th align="left" rowspan="2">Pleiotropy</th>
</tr>
<tr>
<th align="left">OR</th>
<th align="left">95%CI</th>
<th align="left">MR Egger</th>
<th align="left">IVW</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left" rowspan="3">
<italic>H. pylori</italic>
</td>
<td align="left">POAG</td>
<td align="left">66</td>
<td align="left">1.00</td>
<td align="left">0.96 to 1.06</td>
<td align="left">0.980</td>
<td align="left">&#x003e;0.05</td>
<td align="left">&#x003e;0.05</td>
<td align="left">&#x003e;0.05</td>
</tr>
<tr>
<td align="left">NTG</td>
<td align="left">66</td>
<td align="left">0.97</td>
<td align="left">0.86 to 1.08</td>
<td align="left">0.550</td>
<td align="left">&#x003e;0.05</td>
<td align="left">&#x003e;0.05</td>
<td align="left">&#x003e;0.05</td>
</tr>
<tr>
<td align="left">PEG</td>
<td align="left">66</td>
<td align="left">0.99</td>
<td align="left">0.99 to 1.08</td>
<td align="left">0.766</td>
<td align="left">&#x003e;0.05</td>
<td align="left">&#x003e;0.05</td>
<td align="left">&#x003e;0.05</td>
</tr>
<tr>
<td align="left">POAG</td>
<td align="left" rowspan="3">
<italic>H. pylori</italic>
</td>
<td align="left">110</td>
<td align="left">1.01</td>
<td align="left">0.97 to 1.05</td>
<td align="left">0.693</td>
<td align="left">&#x003e;0.05</td>
<td align="left">&#x003e;0.05</td>
<td align="left">&#x003e;0.05</td>
</tr>
<tr>
<td align="left">NTG</td>
<td align="left">68</td>
<td align="left">1.00</td>
<td align="left">0.96 to 1.03</td>
<td align="left">0.804</td>
<td align="left">&#x003e;0.05</td>
<td align="left">&#x003e;0.05</td>
<td align="left">&#x003e;0.05</td>
</tr>
<tr>
<td align="left">PEG</td>
<td align="left">60</td>
<td align="left">0.99</td>
<td align="left">0.96 to 1.01</td>
<td align="left">0.363</td>
<td align="left">&#x003e;0.05</td>
<td align="left">&#x003e;0.05</td>
<td align="left">&#x003e;0.05</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>Note: OR, odds ratio; Heterogeneity, <italic>p</italic>-value for Cochran&#x2019;s Q test; Pleiotropy, <italic>p</italic>-value for MR-Egger intercept test; N. SNPs, number of single-nucleotide polymorphisms used in MR; POAG, primary open-angle glaucoma; NTG, normal tension glaucoma; PEG, pseudo-exfoliation glaucoma; <italic>H. pylori</italic>, <italic>Helicobacter pylori</italic>.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>No significant causal relationship between <italic>H. pylori</italic> infection and POAG risk. <bold>(A)</bold> Forest plot where each black point represents the log odds ratio (OR) and red points showing the combined causal estimate using all SNPs together in a single instrument, using each of the two different methods (inverse variance weighted [IVW] random effects and MR-Egger). Horizontal lines denote 95% confidence intervals (95%CIs). <bold>(B)</bold> Scatter plot of the causal relationships between <italic>H. pylori</italic> infection and POAG using different MR methods. Slope of each line corresponding to the causal estimates for each method. Individual SNP effect on the outcome (point and vertical line) against its effect on the exposure (point and horizontal line) is delineated in the background. <bold>(C)</bold> MR leave-one-out sensitivity analysis. Each black point represents the IVW MR method applied to estimate the causal effect excluding that particular variant from the analysis. The red point depicts the IVW estimate using all SNPs. There are no instances where the exclusion of one particular SNP leads to dramatic changes in the overall result. <bold>(D)</bold> Funnel plot showing the causal effect estimated using each individual SNP as a separate instrument against the inverse of the standard error of the causal estimate. Vertical lines show the causal estimates using all SNPs combined into a single instrument for each of the two different methods (IVW random effects and MR-Egger). There is no significant asymmetry in the plot. 1. Causal estimates for <italic>H. pylori</italic> infection on POAG. 2. Causal estimates for POAG on <italic>H. pylori</italic> infection.</p>
</caption>
<graphic xlink:href="fgene-15-1368915-g003.tif"/>
</fig>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>No significant causal relationship between <italic>H. pylori</italic> infection and NTG risk. <bold>(A)</bold> Forest plot where each black point represents the log odds ratio (OR) and red points showing the combined causal estimate using all SNPs together in a single instrument, using each of the two different methods (inverse variance weighted [IVW] random effects and MR-Egger). Horizontal lines denote 95% confidence intervals (95%CIs). <bold>(B)</bold> Scatter plot of the causal relationships between <italic>H. pylori</italic> infection and POAG using different MR methods. Slope of each line corresponding to the causal estimates for each method. Individual SNP effect on the outcome (point and vertical line) against its effect on the exposure (point and horizontal line) is delineated in the background. <bold>(C)</bold> MR leave-one-out sensitivity analysis. Each black point represents the IVW MR method applied to estimate the causal effect excluding that particular variant from the analysis. The red point depicts the IVW estimate using all SNPs. There are no instances where the exclusion of one particular SNP leads to dramatic changes in the overall result. <bold>(D)</bold> Funnel plot showing the causal effect estimated using each individual SNP as a separate instrument against the inverse of the standard error of the causal estimate. Vertical lines show the causal estimates using all SNPs combined into a single instrument for each of the two different methods (IVW random effects and MR-Egger). There is no significant asymmetry in the plot. 1. Causal estimates for <italic>H. pylori</italic> infection on NTG. 2. Causal estimates for NTG <italic>on H. pylori</italic> infection.</p>
</caption>
<graphic xlink:href="fgene-15-1368915-g004.tif"/>
</fig>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>No significant causal relationship between <italic>H. pylori</italic> infection and PEG risk. <bold>(A)</bold> Forest plot where each black point represents the log odds ratio (OR) and red points showing the combined causal estimate using all SNPs together in a single instrument, using each of the two different methods (inverse variance weighted [IVW] random effects and MR-Egger). Horizontal lines denote 95% confidence intervals (95%CIs). <bold>(B)</bold> Scatter plot of the causal relationships between <italic>H. pylori</italic> infection and POAG using different MR methods. Slope of each line corresponding to the causal estimates for each method. Individual SNP-effect on the outcome (point and vertical line) against its effect on the exposure (point and horizontal line) is delineated in the background. <bold>(C)</bold> MR leave-one-out sensitivity analysis. Each black point represents the IVW MR method applied to estimate the causal effect excluding that particular variant from the analysis. The red point depicts the IVW estimate using all SNPs. There are no instances where the exclusion of one particular SNP leads to dramatic changes in the overall result. <bold>(D)</bold> Funnel plot showing the causal effect estimated using each individual SNP as a separate instrument against the inverse of the standard error of the causal estimate. Vertical lines show the causal estimates using all SNPs combined into a single instrument for each of the two different methods (IVW random effects and MR-Egger). There is no significant asymmetry in the plot. 1. Causal estimates for <italic>H. pylori</italic> infection on PEG. 2. Causal estimates for PEG on <italic>H. pylori</italic> infection.</p>
</caption>
<graphic xlink:href="fgene-15-1368915-g005.tif"/>
</fig>
</sec>
<sec id="s4" sec-type="discussion">
<title>4 Discussion</title>
<p>In the present study, we investigated the association between glaucoma risk and <italic>H. pylori</italic> infection using the bidirectional two-sample MR method, firstly, and demonstrating that there was no significant causal relationship between <italic>H. pylori</italic> infection and the risk of glaucoma.</p>
<p>In the early 2000&#xa0;s, studies on the association between glaucoma and <italic>H. pylori</italic> marked a significant development. In 2001, an investigation on the potential link between <italic>H. pylori</italic> infection and glaucoma was undertaken by <xref ref-type="bibr" rid="B11">Kountouras et al. (2001)</xref> who were among the pioneers in this exploration. They postulated that a theoretical relationship exists between glaucoma and <italic>H. pylori</italic> infection, based on the following considerations: (1) both ailments predominantly affect older adults in the developed world; (2) chronic <italic>H. pylori</italic> infection has the potential to induce systemic disorders affecting vascular tone through the release of vasoactive and proinflammatory substances; and (3) <italic>H. pylori</italic> infection correlates with increased platelet activation and aggregation induced by arteriosclerosis. To investigate this hypothesis, a prospective non-randomized comparative study was conducted, (based on a sample of 32 patients with POAG, 9 patients with PEG and a control group of 30 age-matched anemic patients). The objective was to ascertain the prevalence of <italic>H. pylori</italic> infection in both patients with glaucoma and the anemic control participants. The findings of the study led to the conclusion that <italic>H. pylori</italic> infection is encountered more frequently among patients with glaucoma compared to the general population. These results were presented in part at the sixth congress of the European Glaucoma Society in London, England, in June 2000.</p>
<p>In a continuation of this investigation (<xref ref-type="bibr" rid="B12">Kountouras et al., 2002</xref>), the same researchers demonstrated that over an extended period, individuals with glaucoma experience advantages in terms of the regulation of intraocular pressure and visual field parameters when <italic>H. pylori</italic> is effectively eliminated. The same research team further identified the presence of positive IgG antibodies of <italic>H. pylori</italic> in the anterior chamber of the eyes of patients with POAG and PEG, as opposed to the control group (<xref ref-type="bibr" rid="B13">Kountouras et al., 2003</xref>). In a 2011 study by Kountouras and Zavos (<xref ref-type="bibr" rid="B20">Zavos et al., 2012</xref>), the histological examination of eye biopsies from patients with POAG revealed the presence of <italic>H. pylori</italic> bacteria. Conversely, the results of a Canadian prospective case-control study suggested no association between exposure to <italic>H. pylori</italic> infection and open-angle glaucoma (<xref ref-type="bibr" rid="B8">Galloway et al., 2003</xref>). Furthermore, in an Israeli prospective, population-based study (<xref ref-type="bibr" rid="B14">Kurtz et al., 2008</xref>), it was concluded that neither <italic>H. pylori</italic> infection nor seropositivity for virulent CagA-bearing <italic>H. pylori</italic> strains is significantly associated with the occurrence of any type of glaucoma.</p>
<p>Interestingly, Chen et al. conducted a cohort study in Taiwan involving 6,061 patients with peptic ulcer undergoing <italic>H. pylori</italic> eradication therapy (<xref ref-type="bibr" rid="B4">Chen et al., 2015</xref>) The findings revealed that irrespective of whether <italic>H. pylori</italic> eradication was initiated early or late, it did not significantly decrease the risk of glaucoma in individuals with peptic ulcer disease when compared to a normal control group. The existing body of research examining the potential connection between <italic>H. pylori</italic> infection and glaucoma has produced conflicting results, with some studies suggesting a positive association and others finding no clear link, leading to ongoing controversy in this area.</p>
<p>Hence, Doulberis et al. undertook a comprehensive examination and synthesis of observational studies (<xref ref-type="bibr" rid="B6">Doulberis et al., 2020</xref>). The meta-analysis comprised 15 studies involving 2,664 participants (872 with glaucoma and 1,792 controls). The findings revealed a positive correlation between active <italic>H. pylori</italic> infection and glaucoma. However, when considering glaucoma subtypes, the association was significant for <italic>H. pylori</italic> infection with POAG or NTG, but not with PEG.</p>
<p>While many observational studies have explored potential risk factors for glaucoma, the causal link between these factors and the onset of glaucoma remains uncertain due to the constraints of observational research. In contrast, MR serves as an epidemiological analytical approach that enhances causal inference. It mimics a naturally occurring randomized controlled trial, providing a valuable tool for identifying risk factors and causal relationships with fewer confounding factors compared to traditional observational epidemiological studies (<xref ref-type="bibr" rid="B16">Smith, 2010</xref>; <xref ref-type="bibr" rid="B1">Birney, 2022</xref>).</p>
<p>The findings of the present study contradict those of the meta-analysis, indicating that an <italic>H. pylori</italic> infection does not pose a risk for glaucoma. Consequently, it is reasonable to consider the possibility that these conditions may have shared predisposing or precipitating factors. Various theories explaining the pathogenic mechanism of this condition have been suggested, given that both illnesses are more prevalent among older adults (<xref ref-type="bibr" rid="B7">Eusebi et al., 2014</xref>; <xref ref-type="bibr" rid="B9">Kang and Tanna, 2021</xref>).</p>
<p>One potential theory suggests that aging may be a shared factor in both <italic>H. pylori</italic> infection and glaucoma (<xref ref-type="bibr" rid="B6">Doulberis et al., 2020</xref>). Given these factors, additional research is necessary to thoroughly explore the potential influence of <italic>H. pylori</italic> infection on the development of glaucoma associated with aging.</p>
<p>Nevertheless, our study has certain constraints. Initially, the identification of <italic>H. pylori</italic> infection relied on serological testing within the GWAS data, introducing potential bias in the detection of <italic>H. pylori</italic> infection. Additionally, our dataset exclusively comprised the European population, implying that the applicability of our findings to non-Europeans should be approached with caution. Lastly, we incorporated only those SNPs with a genome-wide significance level (<italic>p</italic> &#x003c; 5 &#xd7; 10<sup>&#x2212;5</sup>), excluding variants genuinely associated with the condition that did not meet this stringent <italic>p</italic>-value threshold, and the sample size for <italic>H. Pylori</italic> may suffer from having a small sample size of less than 5,000 participants.</p>
</sec>
<sec id="s5" sec-type="conclusion">
<title>5 Conclusion</title>
<p>Our findings suggest that there is insufficient genetic evidence to support a causal relationship between <italic>H. pylori</italic> infection and glaucoma. Therefore, the eradication or prevention of <italic>H. pylori</italic> infection may not have a significant impact on the development or progression of glaucoma, and <italic>vice versa</italic>. These results underscore the complexity of the relationship between <italic>H. pylori</italic> and glaucoma and emphasize the need for further research to elucidate any potential causal mechanisms or interactions between these conditions.</p>
</sec>
</body>
<back>
<sec id="s6" sec-type="data-availability">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="sec" rid="s12">Supplementary Material</xref>, further inquiries can be directed to the corresponding author.</p>
</sec>
<sec id="s7">
<title>Ethics statement</title>
<p>The studies involving humans were approved by the Ethics Committee of Second Affiliated Hospital of Fujian Medical University. The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study.</p>
</sec>
<sec id="s8">
<title>Author contributions</title>
<p>YZ: Conceptualization, Data curation, Formal Analysis, Funding acquisition, Writing&#x2013;original draft, Writing&#x2013;review and editing. YH: Conceptualization, Funding acquisition, Writing&#x2013;review and editing. YW: Formal Analysis, Writing&#x2013;review and editing. JZ: Conceptualization, Funding acquisition, Writing&#x2013;review and editing. WC: Formal Analysis, Writing&#x2013;review and editing. DX: Formal Analysis, Writing&#x2013;review and editing. MG: Data curation, Writing&#x2013;original draft, Writing&#x2013;review and editing.</p>
</sec>
<sec id="s9" sec-type="funding-information">
<title>Funding</title>
<p>The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This research was supported by Startup Fund for Scientific Research, Fujian Medical University (No. 2021QH1127); Startup Fund for Scientific Research, Fujian Medical University (No. 2020QH1121); Startup Fund for Scientific Research, Fujian Medical University (No. 2020QH1122); Natural Science Foundation of Fujian Province, China (No. 2023J01750).</p>
</sec>
<ack>
<p>The study was based on summary statistics provided by the FinnGen and MRC-IEU consortium. We thank all investigators and consortiums for sharing valuable summary data.</p>
</ack>
<sec id="s10" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s11" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s12">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fgene.2024.1368915/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fgene.2024.1368915/full&#x23;supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="DataSheet1.docx" id="SM1" mimetype="application/docx" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<sec id="s13">
<title>Abbreviations</title>
<p>
<italic>H. pylori</italic>, <italic>Helicobacter pylori</italic>; POAG, primary open-angle glaucoma; NTG, normal tension glaucoma; PEG, pseudo-exfoliation glaucoma; IVW, inverse variance weighted; SNPs, single nucleotide polymorphisms; MR, Mendelian randomization; GWAS, genome-wide relationship studies; EBI, European Bioinformatics Institute; CI, confidence interval; WM, weighted median; WR, Wald ratio; OR, Odds Ratio; MR-PRESSO, Mendelian Randomization Pleiotropy RESidual Sum and Outlier.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Birney</surname>
<given-names>E.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Mendelian randomization</article-title>. <source>Cold Spring Harb. Perspect. Med.</source> <volume>12</volume> (<issue>4</issue>), <fpage>a041302</fpage>. <comment>PMID: 34872952; PMCID: PMC9121891</comment>. <pub-id pub-id-type="doi">10.1101/cshperspect.a041302</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bowden</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Davey Smith</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Burgess</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression</article-title>. <source>Int. J. Epidemiol.</source> <volume>44</volume> (<issue>2</issue>), <fpage>512</fpage>&#x2013;<lpage>525</lpage>. <comment>Epub 2015 Jun 6. PMID: 26050253; PMCID: PMC4469799</comment>. <pub-id pub-id-type="doi">10.1093/ije/dyv080</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bowden</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Davey Smith</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Haycock</surname>
<given-names>P. C.</given-names>
</name>
<name>
<surname>Burgess</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Consistent estimation in mendelian randomization with some invalid instruments using a weighted median estimator</article-title>. <source>Genet. Epidemiol.</source> <volume>40</volume> (<issue>4</issue>), <fpage>304</fpage>&#x2013;<lpage>314</lpage>. <comment>Epub 2016 Apr 7. PMID: 27061298; PMCID: PMC4849733</comment>. <pub-id pub-id-type="doi">10.1002/gepi.21965</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>H. Y.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>C. L.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>W. C.</given-names>
</name>
<name>
<surname>Kao</surname>
<given-names>C. H.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Does <italic>Helicobacter pylori</italic> eradication reduce the risk of open angle glaucoma in patients with peptic ulcer disease?</article-title> <source>Med. Baltim.</source> <volume>94</volume> (<issue>39</issue>), <fpage>e1578</fpage>. <comment>PMID: 26426633; PMCID: PMC4616866</comment>. <pub-id pub-id-type="doi">10.1097/MD.0000000000001578</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Davey Smith</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Hemani</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Mendelian randomization: genetic anchors for causal inference in epidemiological studies</article-title>. <source>Hum. Mol. Genet.</source> <volume>23</volume> (<issue>R1</issue>), <fpage>R89</fpage>&#x2013;<lpage>R98</lpage>. <comment>Epub 2014 Jul 4. PMID: 25064373; PMCID: PMC4170722</comment>. <pub-id pub-id-type="doi">10.1093/hmg/ddu328</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Doulberis</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Papaefthymiou</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Polyzos</surname>
<given-names>S. A.</given-names>
</name>
<name>
<surname>Bargiotas</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Liatsos</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Srivastava</surname>
<given-names>D. S.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Association between active <italic>Helicobacter pylori</italic> infection and glaucoma: a systematic review and meta-analysis</article-title>. <source>Microorganisms</source> <volume>8</volume> (<issue>6</issue>), <fpage>894</fpage>. <comment>PMID: 32545826; PMCID: PMC7355761</comment>. <pub-id pub-id-type="doi">10.3390/microorganisms8060894</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eusebi</surname>
<given-names>L. H.</given-names>
</name>
<name>
<surname>Zagari</surname>
<given-names>R. M.</given-names>
</name>
<name>
<surname>Bazzoli</surname>
<given-names>F.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Epidemiology of <italic>Helicobacter pylori</italic> infection</article-title>. <source>Helicobacter</source> <volume>19</volume>, <fpage>1</fpage>&#x2013;<lpage>5</lpage>. <comment>Suppl 1 PMID: 25167938</comment>. <pub-id pub-id-type="doi">10.1111/hel.12165</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Galloway</surname>
<given-names>P. H.</given-names>
</name>
<name>
<surname>Warner</surname>
<given-names>S. J.</given-names>
</name>
<name>
<surname>Morshed</surname>
<given-names>M. G.</given-names>
</name>
<name>
<surname>Mikelberg</surname>
<given-names>F. S.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>
<italic>Helicobacter pylori</italic> infection and the risk for open-angle glaucoma</article-title>. <source>Ophthalmology</source> <volume>110</volume> (<issue>5</issue>), <fpage>922</fpage>&#x2013;<lpage>925</lpage>. <comment>PMID: 12750090</comment>. <pub-id pub-id-type="doi">10.1016/S0161-6420(03)00093-9</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kang</surname>
<given-names>J. M.</given-names>
</name>
<name>
<surname>Tanna</surname>
<given-names>A. P.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Glaucoma</article-title>. <source>Med. Clin. North Am.</source> <volume>105</volume> (<issue>3</issue>), <fpage>493</fpage>&#x2013;<lpage>510</lpage>. <comment>Epub 2021 Apr 2. PMID: 33926643</comment>. <pub-id pub-id-type="doi">10.1016/j.mcna.2021.01.004</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kingman</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Glaucoma is second leading cause of blindness globally</article-title>. <source>Bull. World Health Organ</source> <volume>82</volume> (<issue>11</issue>), <fpage>887</fpage>&#x2013;<lpage>888</lpage>. <comment>Epub 2004 Dec 14. PMID: 15640929; PMCID: PMC2623060</comment>.</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kountouras</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Mylopoulos</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Boura</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Bessas</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Chatzopoulos</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Venizelos</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2001</year>). <article-title>Relationship between <italic>Helicobacter pylori</italic> infection and glaucoma</article-title>. <source>Ophthalmology</source> <volume>108</volume> (<issue>3</issue>), <fpage>599</fpage>&#x2013;<lpage>604</lpage>. <comment>PMID: 11237916</comment>. <pub-id pub-id-type="doi">10.1016/s0161-6420(00)00598-4</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kountouras</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Mylopoulos</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Chatzopoulos</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Zavos</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Boura</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Konstas</surname>
<given-names>A. G.</given-names>
</name>
<etal/>
</person-group> (<year>2002</year>). <article-title>Eradication of <italic>Helicobacter pylori</italic> may be beneficial in the management of chronic open-angle glaucoma</article-title>. <source>Arch. Intern Med.</source> <volume>162</volume> (<issue>11</issue>), <fpage>1237</fpage>&#x2013;<lpage>1244</lpage>. <comment>PMID: 12038941</comment>. <pub-id pub-id-type="doi">10.1001/archinte.162.11.1237</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kountouras</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Mylopoulos</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Konstas</surname>
<given-names>A. G.</given-names>
</name>
<name>
<surname>Zavos</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Chatzopoulos</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Boukla</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Increased levels of <italic>Helicobacter pylori</italic> IgG antibodies in aqueous humor of patients with primary open-angle and exfoliation glaucoma</article-title>. <source>Graefes Arch. Clin. Exp. Ophthalmol.</source> <volume>241</volume> (<issue>11</issue>), <fpage>884</fpage>&#x2013;<lpage>890</lpage>. <comment>Epub 2003 Oct 24. PMID: 14576945</comment>. <pub-id pub-id-type="doi">10.1007/s00417-003-0779-5</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kurtz</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Regenbogen</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Goldiner</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Horowitz</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Moshkowitz</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>No association between <italic>Helicobacter pylori</italic> infection or CagA-bearing strains and glaucoma</article-title>. <source>J. Glaucoma</source> <volume>17</volume> (<issue>3</issue>), <fpage>223</fpage>&#x2013;<lpage>226</lpage>. <comment>PMID: 18414109</comment>. <pub-id pub-id-type="doi">10.1097/IJG.0b013e31815a34ac</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Skrivankova</surname>
<given-names>V. W.</given-names>
</name>
<name>
<surname>Richmond</surname>
<given-names>R. C.</given-names>
</name>
<name>
<surname>Woolf</surname>
<given-names>B. A. R.</given-names>
</name>
<name>
<surname>Yarmolinsky</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Davies</surname>
<given-names>N. M.</given-names>
</name>
<name>
<surname>Swanson</surname>
<given-names>S. A.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Strengthening the reporting of observational studies in Epidemiology using mendelian randomization: the STROBE-MR statement</article-title>. <source>JAMA</source> <volume>326</volume> (<issue>16</issue>), <fpage>1614</fpage>&#x2013;<lpage>1621</lpage>. <pub-id pub-id-type="doi">10.1001/jama.2021.18236</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smith</surname>
<given-names>G. D.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Mendelian randomization for strengthening causal inference in observational studies: application to gene &#xd7; environment interactions</article-title>. <source>Perspect. Psychol. Sci.</source> <volume>5</volume> (<issue>5</issue>), <fpage>527</fpage>&#x2013;<lpage>545</lpage>. <comment>Epub 2010 Oct 11. PMID: 26162196</comment>. <pub-id pub-id-type="doi">10.1177/1745691610383505</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Swanson</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Tiemeier</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ikram</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hernan</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Nature as a Trialist? deconstructing the analogy between mendelian randomization and randomized trials</article-title>. <source>Epidemiology</source> <volume>28</volume>, <fpage>653</fpage>&#x2013;<lpage>659</lpage>. <pub-id pub-id-type="doi">10.1097/EDE.0000000000000699</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tham</surname>
<given-names>Y. C.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>T. Y.</given-names>
</name>
<name>
<surname>Quigley</surname>
<given-names>H. A.</given-names>
</name>
<name>
<surname>Aung</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>C. Y.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis</article-title>. <source>Ophthalmology</source> <volume>121</volume> (<issue>11</issue>), <fpage>2081</fpage>&#x2013;<lpage>2090</lpage>. <comment>Epub 2014 Jun 26. PMID: 24974815</comment>. <pub-id pub-id-type="doi">10.1016/j.ophtha.2014.05.013</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tsolaki</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Gogaki</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Sakkias</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Skatharoudi</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Lopatatzidi</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Tsoulopoulos</surname>
<given-names>V.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>
<italic>Helicobacter pylori</italic> infection and primary open-angle glaucoma: is there a connection?</article-title> <source>Clin. Ophthalmol.</source> <volume>6</volume>, <fpage>45</fpage>&#x2013;<lpage>47</lpage>. <comment>Epub 2012 Jan 6. PMID: 22259235; PMCID: PMC32590</comment>. <pub-id pub-id-type="doi">10.2147/OPTH.S26659</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zavos</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Kountouras</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Sakkias</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Venizelos</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Deretzi</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Arapoglou</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Histological presence of <italic>Helicobacter pylori</italic> bacteria in the trabeculum and iris of patients with primary open-angle glaucoma</article-title>. <source>Ophthalmic Res.</source> <volume>47</volume> (<issue>3</issue>), <fpage>150</fpage>&#x2013;<lpage>156</lpage>. <comment>Epub 2011 Nov 15. PMID: 22094712</comment>. <pub-id pub-id-type="doi">10.1159/000330053</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zeng</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2023a</year>). <article-title>Causal associations between dried fruit intake and cardiovascular disease: a Mendelian randomization study</article-title>. <source>Front. Cardiovasc Med.</source> <volume>10</volume>, <fpage>1080252</fpage>. <comment>PMID: 36815021; PMCID: PMC9939508</comment>. <pub-id pub-id-type="doi">10.3389/fcvm.2023.1080252</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zeng</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2023b</year>). <article-title>Roles of gut microbiome in epilepsy risk: a Mendelian randomization study</article-title>. <source>Front. Microbiol.</source> <volume>14</volume>, <fpage>1115014</fpage>. <comment>PMID: 36922970; PMCID: PMC10010438</comment>. <pub-id pub-id-type="doi">10.3389/fmicb.2023.1115014</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zeng</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2023c</year>). <article-title>The causal role of gastroesophageal reflux disease in anxiety disorders and depression: a bidirectional Mendelian randomization study</article-title>. <source>Front. Psychiatry</source> <volume>14</volume>, <fpage>1135923</fpage>. <comment>PMID: 36911112; PMCID: PMC9992201</comment>. <pub-id pub-id-type="doi">10.3389/fpsyt.2023.1135923</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>